IRF4 deletion in mice may induce transplant acceptance by establishing CD4+ T-cells dysfunction (58) and render mice resistant to several autoimmune diseases (28), such as ulcerative colitis and experimental autoimmune encephalomyelitis. Here, IRF4 is linked to experimental autoimmune encephalomyelitis.